The world’s most experienced natural products consulting firm, AIBMR has worked with companies in the U.S. & around the globe since 1978. #GRAS#NDI#toxstudies
AIBMR's @doctorendres was interviewed for this piece and shared his thoughts on cannabinoid research, safety, and the government's current regulatory stance.
#CBD & other #cannabinoids are still in play, but responsible manufacturing and research are key to the category’s future. Following FDA's breaking announcement yesterday, Sebastian Krawiec writes about CBD's regulatory path. ➡️ https://t.co/NIC3cD5ns3
#hemp@AIBMRinc@SPINSllc
The AIBMR family joins the Lopez family and all who loved Hector both in grief for his passing and celebration of his brilliant life. We will deeply miss him. @drhectorlopez @doctorendres
https://t.co/Ti9WHX0bSw
AIBMR will be back in Vegas at SSW! Come see us at Booth 3426 to discuss your product regulatory needs, including GRAS, NDI, and toxicology studies. @SupplySide#SSW22
Defending GRAS: Instead of saying GRAS doesn’t work, should we instead be talking about how consumers are using products? ➡️ https://t.co/XLFybWUivU
#dietarysupplement#health#nutrition@AIBMRinc @doctorendres
Check out this link to watch AIBMR's Dr. Endres interviewed on a variety of regulatory topics, including GRAS, tox studies, and CBD! @doctorendres @nutritionalo
https://t.co/Nqu5C9uuwm
Join AIBMR and colleagues on 8/27 for the @AHPAssociation Hemp-CBD Supplement Virtual Congress. This online event features the latest regulatory updates & resources + a keynote by Oregon Senator @RonWyden. Register here: https://t.co/h8JVytnsRu
AIBMR is honored once again to contribute to this event. We will host a workshop providing attendees with an overview of NDI notification and GRAS regulatory requirements (and issues therewith) for hemp and hemp-derived cannabidiol (CBD).
All of us at AIBMR continue to wish you good health and safety during these challenging times. We are also fortunate to be fully operational and remain available to assist with your scientific & regulatory needs. #GRAS#NDI#toxstudies
The AIBMR team is live and direct from Vegas for #SSW19! Anticipating another productive event and many quality conversations about how we can help with your regulatory needs. Come see us at Booth 3320! #GRAS#NDI#toxstudies
This piece on the 25th anniversary of DSHEA includes an interview with our Dr. Schauss, whose work with grassroots organization Citizens for Health was key in levying support for the landmark legislation.
AIBMR's @DrReddeman will be presenting today at @AHPAssociation's Hemp-CBD Supplement Congress. Dr. Reddeman will outline how ingredient manufacturing & identity, exposure estimates, toxicological data and safety assessments are key to successful GRAS & NDI notifications.
@DrReddeman@AHPAssociation AIBMR is grateful for a longstanding collaborative relationship with @AHPAssociation and honored to be included in this landmark natural products industry event.